A team of researchers led by Emanuel Hanski discovered a protein called SilCR that blocks the immune system's distress calls, making Group A Streptococcus bacteria more virulent. The findings could lead to new strategies for treating necrotizing fasciitis and halting its rapid destruction of tissue.
A recent study published in Annals of Surgery found AVELOX to be equally effective as a multi-dose combination therapy for treating intra-abdominal infections, with improved cure rates among hospital-acquired infections. The treatment showed a significantly higher cure rate and better safety profile compared to the standard regimen.
Researchers have developed a 3D modeling technique that shows how antibodies bind to bacterial sugars, allowing for potential new vaccines. This technique can be used to create new vaccines that protect against multiple strains of bacteria.
A recent disease outbreak in China, caused by Streptococcus suis, has resulted in 38 deaths and highlights the importance of occupational exposure to pigs. Researchers found that the pathogen was linked to outbreaks in local pig populations, but a new strain may be responsible for the severity of symptoms.
A 2002 conjunctivitis outbreak at Dartmouth College revealed bacterial pinkeye caused by a strain of Streptococcus pneumoniae lacking protective capsule. Effective collaboration between doctors, health officials, and the CDC helped contain the outbreak through rapid communication and basic hygiene measures.
A rapid test developer suggests a PCR-based approach as an effective alternative to current methods for detecting group A streptococcus in throat swabs. The proposed test offers enhanced sensitivity and faster results compared to traditional antigen testing.